Literature DB >> 21181516

The manufacture of low-dose oral solid dosage form to support early clinical studies using an automated micro-filing system.

Mingda Bi1, Changquan Calvin Sun, Francisco Alvarez, Fernando Alvarez-Nunez.   

Abstract

Automated powder dispensing systems enable supplying early clinical studies using drug-in-capsule approach, which is material sparing and requires a minimum amount of resources. However, the inability of accurately filling the capsule with a small amount, e.g., several micrograms, of drug limits the use of these systems for potent drugs. We demonstrate that formulated powder blends can be used to successfully fill capsules containing 5 μg to 5 mg of drug with adequate content uniformity. Effective formulation and process strategies that enable this approach are presented with examples.
© 2010 American Association of Pharmaceutical Scientists

Mesh:

Substances:

Year:  2010        PMID: 21181516      PMCID: PMC3066335          DOI: 10.1208/s12249-010-9549-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  11 in total

1.  Dry blending process scale-up for a very low dose drug candidate.

Authors:  L S Wu; J Pang; J G Chen; M A Hussain
Journal:  AAPS PharmSciTech       Date:  2000-08-31       Impact factor: 3.246

2.  Particle size and content uniformity.

Authors:  S H Yalkowsky; S Bolton
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

3.  Wet granulation in rotary processor and fluid bed: comparison of granule and tablet properties.

Authors:  Jakob Kristensen; Vibeke Wallaert Hansen
Journal:  AAPS PharmSciTech       Date:  2006-03-10       Impact factor: 3.246

Review 4.  Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.

Authors:  Ewart T Cole; Dominique Cadé; Hassan Benameur
Journal:  Adv Drug Deliv Rev       Date:  2007-11-09       Impact factor: 15.470

5.  Particle size limits to meet USP content uniformity criteria for tablets and capsules.

Authors:  Brian R Rohrs; Gregory E Amidon; Richard H Meury; Pamela J Secreast; Harry M King; Connie J Skoug
Journal:  J Pharm Sci       Date:  2006-05       Impact factor: 3.534

6.  Improving the content uniformity of a low-dose tablet formulation through roller compaction optimization.

Authors:  Mary T am Ende; Sara K Moses; Anthony J Carella; Rashmi A Gadkari; Timothy W Graul; Angel L Otano; Robert J Timpano
Journal:  Pharm Dev Technol       Date:  2007       Impact factor: 3.133

7.  Content uniformity of potent drugs in tablets.

Authors:  N A Orr; E A Sallam
Journal:  J Pharm Pharmacol       Date:  1978-12       Impact factor: 3.765

8.  Studies on mixing cohesive powders.

Authors:  E Shotton; N A Orr
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

9.  Particle size distribution of the active ingredient for solid dosage forms of low dosage.

Authors:  M C Johnson
Journal:  Pharm Acta Helv       Date:  1972 Aug-Sep

10.  The filling of molten and thixotropic formulations into hard gelatin capsules.

Authors:  S E Walker; J A Ganley; K Bedford; T Eaves
Journal:  J Pharm Pharmacol       Date:  1980-06       Impact factor: 3.765

View more
  3 in total

1.  Spherical Agglomerates of Lactose Reduce Segregation in Powder Blends and Improve Uniformity of Tablet Content at High Drug Loads.

Authors:  Dejan Lamešić; Blaž Grilc; Robert Roškar; Selina Kolokytha; Jürgen Hofmann; Andreas Malekos; Rolf Kaufmann; Odon Planinšek
Journal:  AAPS PharmSciTech       Date:  2021-12-10       Impact factor: 3.246

2.  Implementation of a New Electronic Liquid Dispensing System for Individualized Compounding of Hard Capsules.

Authors:  Bakul Sarker; Mariele Fligge; Tanja Knaab; Jörg Breitkreutz
Journal:  Pharmaceutics       Date:  2022-07-29       Impact factor: 6.525

3.  Tailoring Rational Manufacturing of Extemporaneous Compounding Oral Dosage Formulations with a Low Dose of Minoxidil.

Authors:  Carlos Torrado-Salmeron; Almudena Laguna; Alicia Guillén; Miguel G Saro; Antonio Matji; Juan J Torrado; Dolores R Serrano
Journal:  Pharmaceutics       Date:  2022-03-17       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.